Co-diagnostics, inc. to participate in the piper sandler 35th annual healthcare conference in new york city on november 30, 2023

Salt lake city , nov. 29, 2023 /prnewswire/ -- co-diagnostics, inc. (nasdaq-cm: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that co-diagnostics will be presenting at the piper sandler 35th annual healthcare conference in new york city, new york on november 30, 2023. the presentation will be conducted by co-diagnostics ceo dwight egan at 12:10 pm est and will include a discussion of company progress on its forthcoming co-dx™ at-home and point-of-care pcr platform*.
CODX Ratings Summary
CODX Quant Ranking